Search Results for: National Institute of Neurological Disorders and Stroke"

National HIV/AIDS and Aging Awareness Day: A Perspective from the National Institutes of Health

Co-authored by Scott Proestel, M.D., Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH

On September 18, 2011, we mark the fourth observance of National HIV/AIDS and Aging Awareness Day. The remarkable success of antiretroviral therapies in prolonging the lives of HIV-infected individuals who have access to and can tolerate these drugs has

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

nih logo

For Immediate Release: Wednesday, May 27, 2015 NIH-funded trial results likely will impact global treatment guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune…